linc-SCRG1 accelerates liver fibrosis by decreasing RNA-binding protein tristetraprolin.
Wu JC, Luo SZ, Liu T, Lu LG, Xu MY.
Wu JC, et al.
FASEB J. 2019 Feb;33(2):2105-2115. doi: 10.1096/fj.201800098RR. Epub 2018 Sep 18.
FASEB J. 2019.
PMID: 30226813
Inhibition of linc-SCRG1 may be a novel therapeutic approach to inactivate HSCs and extenuate human liver fibrosis.-Wu, J.-C., Luo, S.-Z., Liu, T., Lu, L.-G., Xu, M.-Y. linc-SCRG1 accelerates liver fibrosis by decreasing RNA-binding protein tristetraprolin....
Inhibition of linc-SCRG1 may be a novel therapeutic approach to inactivate HSCs and extenuate human liver fibrosis.-Wu, J.-C., Luo, …